Dr. rer. nat. Simon Völkl

Department of Medicine 5 – Haematology and Oncology

Early Expansion of CD19.CAR-T Cells in vivo identify the Patients at Risk for the Treatment Failure in diffuse large B-Cell Lymphoma (2022) Blumenberg V, Busch G, Baumann S, Jitschin R, Winkelmann M, Hellwig K, Schmidt C, et al. Conference contribution Increased CD47 expression inhibits phagocytosis of alloreactive donor T cells after allo-HSCT (2022) Flamann C, Matos C, Kreutz M, Shaikh H, Beilhack A, Büttner-Herold M, Lischer C, et al. Conference contribution Single-cell Transcriptome Analysis and clonal Kinetics in a Patient after CD19.CAR-T Cell Therapy (2022) Lischer C, Eisenhauer N, Aigner M, Jacobs B, Schletter M, Gebhard C, Rehli M, et al. Conference contribution Immunometabolic alteration in NK cells from multiple myeloma patients (2022) Jacobs B, Richter S, Stoll A, Völkl S, Mackensen A, Mougiakakos D Conference contribution CAR-T CELL TREATMENT OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS- SAFETY AND PRELIMINARY EFFICACY DATA FROM THE FIRST FOUR PATIENTS (2022) Schett G, Böltz S, Müller F, Kleyer A, Völkl S, Aigner M, Gary R, et al. Conference contribution Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL (2022) Cobo MFL, Ritter J, Gary R, Seitz V, Mautner J, Aigner M, Völkl S, et al. Journal article Natural NADH and FAD Autofluorescence as Label-Free Biomarkers for Discriminating Subtypes and Functional States of Immune Cells (2022) Lemire S, Thoma OM, Kreiß L, Völkl S, Friedrich O, Neurath M, Schürmann S, Waldner M Journal article, Original article Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus (2022) Kretschmann S, Völkl S, Reimann H, Krönke G, Schett G, Achenbach S, Lutzny-Geier G, et al. Journal article Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset. (2022) Böttcher M, Panagiotidis K, Bruns H, Stumpf M, Völkl S, Geyh S, Dietel B, et al. Journal article Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (2022) Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, et al. Journal article